Post-COVID-19 Epidemiology of Bronchiolitis: We Are (Not) Returning to the Past
The Pediatric Infectious Disease Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
To
the
Editors:
In
2024,
Pediatric
Infectious
Disease
Journal
presented
findings
of
an
Italian
study
analyzing
how
coronavirus
disease
2019
(COVID-19)
pandemic
influenced
viral
bronchiolitis'
characteristics.1
The
authors
recommended
that
hospitals
maintain
a
high
level
surveillance
epidemiological
changes
to
ensure
prompt
response
and
proper
allocation
resources.
Considering
profound
impact
bronchiolitis
epidemiology
modifications
in
our
setting,2,3
these
observations
prompted
us
monitor
admissions
during
2023–2024
epidemic
season
continue
describing
trends
we
have
already
reported
since
before
start
pandemic.2,3
For
this
purpose,
included
all
children
0–2
years
with
International
Classification
Diseases,
9th
revision
diagnosis
admitted
Istituto
Gaslini,
Italy,
from
1
October
2023
30
April
2024
compared
previous
6
seasons.
region,
typically
followed
seasonal
pattern
prepandemic
era,
starting
December,
peaking
January
February,
decreasing
spring.2
These
been
drastically
disrupted
by
COVID-19
related
preventive
interventions
resulting
disappearance
year
2020–2021.
2021–2022
season,
after
relaxation
pandemic-related
measures,
huge
significantly
early
peak
was
detected,
gradual
shift
curve
2022–2023
always
increased
although
less
anticipated
peak.
last
hospitalizations
distribution
seemed
be
realigning
late
November,
December
January,
ending
spring,
thus
suggesting
possible
"return
past"
(Fig.
1A).FIGURE
1.:
Trend
seasons
(1
October–30
April)
2017–2024
period
at
Gaslini
Institute,
Genoa,
Italy
(A)
corresponding
absolute
numbers,
annual
rate
per
1000
prevalence
RSV
100
tested
(B).
indicates
respiratory
syncytial
virus.However,
total
remained
largely
over
300,
three
times
more
than
years.
admission
for
7.7
20
×
1B),
absence
rising
regional
birth
rates,4
incidence
ratio
being
2.7
(95%
confidence
interval:
2.1–3.3,
P
<
0.001)
higher
2017–2018
season.
Although
temporal
seems
resemble
trend
were
used
to,
appears
persistently
enhanced.
reason
phenomenon
is
not
easily
understandable.
A
partial
explanation
could
found
virus,
which
went
cause
50–60%
70–80%
postpandemic
era.
This
reflect
reduced
population
exposure
viruses
pandemic,
vulnerability
among
infants
susceptibility
sustained
circulation
virus
also
support
supposed
severity
years.5
conclusion,
transition
beginning
observed,
setting
burden
overwhelming
universal
prevention
measures
available
other
countries.
Close
monitoring
remains
crucial
fully
understand
long-term
effects
assess
hopefully
significant
prophylaxis.
Language: Английский
Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study
International Journal of Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
148, P. 107231 - 107231
Published: Sept. 1, 2024
Language: Английский
Severe bronchiolitis before and after the COVID-19 pandemic: a retrospective database analysis by the Italian Network of PICU study group (TIPNet)
Journal of Anesthesia Analgesia and Critical Care,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: Nov. 26, 2024
Abstract
Background
The
first
post-COVID-19
pandemic
year
demonstrated
an
unusual
bronchiolitis
epidemic
in
both
hemispheres
and
has
been
attributed
to
the
removal
of
barriers
implemented
during
SARS-CoV-2
infection.
Several
countries
reported
increase
respiratory
syncytial
virus
(RSV)
bronchiolitis,
with
more
hospitalizations
a
greater
need
for
support.
We
aimed
evaluate
consequences
COVID-19
on
epidemiology
management
severe
pediatric
intensive
care
units
(PICUs)
Italy.
Methods
Multicenter,
retrospective,
cohort
database
analysis.
All
children
younger
than
24
months
admitted
7
PICUs
from
October
2017
April
2023
diagnosed
were
included.
compared
patients
pre-COVID
post-COVID
eras,
excluding
2020–2021
season
due
low
numbers.
Logistic
regression
models
used
assess
impact
pre-/post-COVID
period
invasive
ventilation.
Results
Seven
hundred
fifteen
PICU
study
period,
451
251
post-COVID.
Patients
group
older,
had
comorbidities,
higher
Pediatric
Index
Mortality
scores
at
admission
but
support
was
not
significantly
different.
There
high
variability
across
centers.
Presenting
protective
against
risk
mechanical
ventilation,
adjusted
age
disease
severity
(OR
0.38,
95%
CI
0.16–0.89),
while
RSV
infection
increased
intubation
2.49,
1.1–5.63).
Conclusions
have
faced
unexpected
peak
cases
after
pandemic,
which
did
require
Language: Английский
Changes in entire acute bronchiolitis seasons before, during, and after the COVID-19 pandemic in Spain.
Juan Manuel Rius‐Peris,
No information about this author
M. Castelló,
No information about this author
Marta Pareja León
No information about this author
et al.
Infection Prevention in Practice,
Journal Year:
2024,
Volume and Issue:
6(4), P. 100399 - 100399
Published: Sept. 23, 2024
Language: Английский
Prophylaxis with palivizumab in a six‐year‐old girl with Down syndrome and postinfectious obliterative bronchiolitis
Francesca Peri,
No information about this author
Davide Atti,
No information about this author
Gilda Paternuosto
No information about this author
et al.
Pediatric Pulmonology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 29, 2024
The
authors
declare
no
conflicts
of
interest.
data
are
available
from
the
corresponding
author
at
this
mail
address
francesca.
peri@burlo.
trieste.
it,
upon
reasonable
request.
Language: Английский